Set an alarm for Sunday

The Non-Dollar Report Monday, August 24, 2015 Dear Non-Dollar Report Reader,   Highlight it on your calendar.   Set the alarm on your smartphone.   Do whatever you need to do in order to remember this date: Sunday, August 30.   Oxford Club biotech expert Marc Lichtenfeld recently broke the news about a specific time and location at which one company will make a blockbuster announcement on a prized drug.   It's an announcement so important to the general public that the U.S. government already issued this company a coveted "special status."   It's an extremely rare classification that grants it: Seven years of market exclusivity A fast track through the FDA approval process And, according to The Oxford Club, a conservative future sales projection of $329 million on each of the company's seven drugs. Bottom line - a virtually unknown biotech with revenue estimated to ratchet up from $60 million... to more than $2.31 billion... is on the verge of a potentially astronomical stock surge.   It comes as no surprise that Vanguard, BlackRock and Morgan Stanley snatched up more than a million shares each.   Meanwhile, the company's CEO has upped his investment to $14.5 million of his own money.   Click here to access the complete story directly from Marc.   These critical details are ONLY available before Sunday.   Sincerely, Eric J. Fry Founder, The Non-Dollar Report You are receiving this email because you subscribed to The Non-Dollar Report. To unsubscribe from The Non-Dollar Report or to manage your account, click here. To cancel by mail or for any other subscription issues, write us at: The Non-Dollar Report Attn: Member Services 14 West Mount Vernon Place Baltimore, MD 21201 © 2015 Beyond the Dollar LLC, All Rights Reserved North America: 1 877 880 9290; Fax: 1 410 329 1923 International: +1 443 353 4461; Fax: +1 410 329 1923 Questions? Comments? Contact us here. Beyond the Dollar LLC is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by Beyond the Dollar should be made only after consulting with your financial advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the World Wide Web), in whole or in part, is strictly prohibited without the express written permission of Beyond the Dollar LLC, 14 West Mt. Vernon Place, Baltimore MD 21201.